January 25, 2021
Japanese dermatology powerhouse Maruho, which markets the prescription drug for blood flow improvement/skin-moisturizing Hirudoid (heparinoid), said on January 22 that it filed a request seeking a temporary injunction against Kenei Pharmaceutical to stop the company from selling its OTC medicine...read more